430 related articles for article (PubMed ID: 21242408)
21. Treatment of axillary and palmar hyperhidrosis with botulinum toxin.
Goldman A
Aesthetic Plast Surg; 2000; 24(4):280-2. PubMed ID: 10954791
[TBL] [Abstract][Full Text] [Related]
22. Muscle weakness in treatment of palmar hyperhidrosis with botulinum toxin type a: can it be prevented?
Kouris A; Vavouli C; Markantoni V; Kontochristopoulos G
J Drugs Dermatol; 2014 Nov; 13(11):1315-6. PubMed ID: 25607695
[TBL] [Abstract][Full Text] [Related]
23. Relapsing-remitting severe generalized muscular weakness after botulinum toxin treatment for hyperhidrosis.
Chiarello D; Piombo M; Corbetto M; Di Pino G; Assenza G; Capone F; Di Lazzaro V
Muscle Nerve; 2014 Sep; 50(3):456-7. PubMed ID: 24890202
[No Abstract] [Full Text] [Related]
24. Botulinum toxin type B: a new therapy for axillary hyperhidrosis.
Nelson L; Bachoo P; Holmes J
Br J Plast Surg; 2005 Mar; 58(2):228-32. PubMed ID: 15710119
[TBL] [Abstract][Full Text] [Related]
25. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
J Am Acad Dermatol; 2013 Dec; 69(6):960-4. PubMed ID: 24035554
[TBL] [Abstract][Full Text] [Related]
26. Treatment of hyperhidrosis with botulinum toxin.
Doft MA; Hardy KL; Ascherman JA
Aesthet Surg J; 2012 Feb; 32(2):238-44. PubMed ID: 22328694
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
28. Axillary hyperhidrosis: treatment with botulinum toxin A.
Odderson IR
Arch Phys Med Rehabil; 1998 Mar; 79(3):350-2. PubMed ID: 9523792
[TBL] [Abstract][Full Text] [Related]
29. Primary frontal hyperhidrosis successfully treated with low doses of botulinum toxin A as a useful alternative to surgical treatment.
Santana-Rodríguez N; Clavo-Varas B; Ponce-González MÁ; Jarabo-Sarceda JR; Pérez-Alonso D; Ruiz-Caballero JA; Olmo-Quintana V; Atallah Yordi N; Fiuza-Pérez MD
J Dermatolog Treat; 2012 Feb; 23(1):49-51. PubMed ID: 20964567
[TBL] [Abstract][Full Text] [Related]
30. Hyperhidrosis of face and scalp: repeated successful treatment with botulinum toxin type A.
Komericki P; Ardjomand N
Indian J Dermatol Venereol Leprol; 2012; 78(2):201-2. PubMed ID: 22421660
[No Abstract] [Full Text] [Related]
31. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
32. Treatment of axillary hyperhidrosis with botulinum toxin: a single surgeon's experience with 53 consecutive patients.
Doft MA; Kasten JL; Ascherman JA
Aesthetic Plast Surg; 2011 Dec; 35(6):1079-86. PubMed ID: 21559989
[TBL] [Abstract][Full Text] [Related]
33. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
Naumann MK; Hamm H; Lowe NJ;
Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
[TBL] [Abstract][Full Text] [Related]
34. Axillary injection of botulinum A toxin in a patient with muscle cramps associated with severe axillary hyperhidrosis.
Filosto M; Bertolasi L; Fincati E; Priori A; Tomelleri G; Chieregato G; Rizzuto N
Acta Neurol Belg; 2001 Jun; 101(2):121-3. PubMed ID: 11486559
[TBL] [Abstract][Full Text] [Related]
35. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval.
Wollina U; Karamfilov T; Konrad H
J Am Acad Dermatol; 2002 Apr; 46(4):536-40. PubMed ID: 11907503
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
Chankrachang S; Arayawichanont A; Poungvarin N; Nidhinandana S; Boonkongchuen P; Towanabut S; Sithinamsuwan P; Kongsaengdao S
Headache; 2011 Jan; 51(1):52-63. PubMed ID: 21083558
[TBL] [Abstract][Full Text] [Related]
37. The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.
Glaser DA
Neurotox Res; 2006 Apr; 9(2-3):173-7. PubMed ID: 16785115
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin-B and the management of hyperhidrosis.
Baumann LS; Halem ML
Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547
[TBL] [Abstract][Full Text] [Related]
39. Reconstituted and frozen botulinum toxin A is as effective and safe as fresh for treating axillary hyperhidrosis: A retrospective study.
Shayesteh A; Boman A; Hawas E; Carlberg B
PLoS One; 2023; 18(12):e0295393. PubMed ID: 38048338
[TBL] [Abstract][Full Text] [Related]
40. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
Skroza N; Bernardini N; La Torre G; La Viola G; Potenza C
Acta Dermatovenerol Croat; 2011; 19(1):16-20. PubMed ID: 21489361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
